Answers are grounded in this paper and cite their sources.
Several challenges still exist to adopt the anti-müllerian hormone (AMH) as a marker of polycystic ovary morphology, as included in the recently updated international guideline. Although different evaluations of age- and assay-specific reference ranges have been published in the past few years, these studies have mainly been conducted in normo-ovulatory or infertile women.
No takes yet. Share an insight, caveat, or question.
Barbagallo et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: